On February 7th 2017 – Aurora cannabis made a submission to CPA source a website that helps find chartered accountants jobs. Aurora cannabis is currently seeking a new CFO to replace Michael Singer who is acting as a CFO consultant at the moment for Aurora cannabis.
Michael Singer the current CFO consultant for Aurora is currently the CFO of clementia pharmaceuticals. At the pace Aurora cannabis is growing they need a fully dedicated CFO to grow with the company, Mr.singer has been doing a great job so far but the company needs a dedicated CFO to keep up with the expanding company.
Aurora cannabis is looking a for new CFO to start by April 10th 2017.
Michael Singer is an accomplished pharmaceutical industry executive and CFO consultant who has held a number of senior finance and governance roles. Michael is currently Chief Financial Officer for Clementia Pharmaceuticals Inc., a clinical stage biopharmaceutical company developing treatments for people with rare diseases.
Previously, he was CFO of Bedrocan Canada Inc. and successfully transitioned the company onto the TSXV in August 2014. Prior to Bedrocan, he served as CFO of Thallion Pharmaceuticals (TSXV: TLN) (previously Caprion Pharmaceuticals) from 2000 until its sale to BELLUS Health in 2013.
Until July 2014, he served as Chairman of the Board of Warnex Inc. (TSXV: WNX.H) until successful completion of the company’s amalgamation with Diagnos Inc. (TSXV: ADK), where he continued to serve as an independent director until July 2016.
Michael graduated from McGill University (1991) and is a Certified Professional Accountant – Certified General Accountant with the Ordre des CPA du Québec.